The four botanicals with a federal page, quoted in full
Asian ginseng, hawthorn, saw palmetto and ginkgo.
Asian ginseng: insomnia, blood sugar, and rare liver damage
NCCIH on short-term use: “Short-term oral use (by mouth, up to 6 months) of Asian ginseng in recommended amounts appears to be safe for most people.” That is the
reassuring half, and it is worth printing first.
On the most common effect: “Insomnia (trouble sleeping) is the herb’s most common side effect.” That is
worth knowing on a product whose front panel calls itself a day and night formula while
the directions never split the serving. On blood sugar:
“Asian ginseng might lower blood sugar levels.” On the uncommon end:
“Uncommon side effects that have been reported include severe rash, liver damage, and severe allergic reactions.” And on conditions:
“Asian ginseng may worsen autoimmune disorders and interfere with blood clotting.”
Hawthorn: side effects, and a sixteen-week line nobody has crossed
Hawthorn is the joint-largest row on this panel at 250 mg. NCCIH lists possible
side effects as “dizziness, nausea, vomiting, diarrhea, and muscle pain.” The more useful statement is
about duration: “No research studies have tested whether it is safe to use hawthorn for more than 16 weeks.” Sixteen weeks is about 112 days;
the six-bottle pack is 180. Nobody has shown a problem, and nobody has looked.
Saw palmetto: well tolerated, and a note that matters if you are monitored
The friendliest safety entry on the panel. NCCIH:
“Saw palmetto is well tolerated.” Adverse effects are reported as mild and
infrequent.
One note is worth printing in full, because men taking this ingredient are often the
same men having a blood test for it:
“Saw palmetto does not appear to affect readings of prostate-specific antigen (PSA) levels, even when taken in higher-than-usual amounts.” That cuts in the product’s favour. For
completeness: “Saw palmetto may be unsafe for use during pregnancy or while breastfeeding.”
Ginkgo, and the seven with nothing to quote
Ginkgo’s safety statements are in the bleeding section above. Its effectiveness
statement belongs here. NCCIH: “There’s no conclusive evidence that ginkgo is helpful for any health condition.”
Epimedium, damiana, muira puama, catuaba, tribulus, oat straw and cayenne have no
NCCIH page and no ODS fact sheet, so there is no federal safety statement to print for
any of them in either direction.